# Novo Nordisk to invest $1.2B in new bio-manufacturing operations in Clayton, North Carolina

Novo Nordisk will invest $1.2 billion to build new bio-manufacturing operations at its Clayton, North Carolina campus to produce the active ingredient for its insulin products. The project will create 691 jobs.

- Type: Expansion
- Announced: 2019-01-11
- Where: Clayton, Johnston County, North Carolina, United States
- Value: $1.20B
- Jobs: 691
- Status: announced
- Products: active ingredient for insulin products
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Novo Nordisk](https://endata.com/companies/17868.md)

## Sources

- [growwithjoco.com](https://www.growwithjoco.com/news/novo-nordisk-to-add-major-new-bio-manufacturing-operations-in-clayton/), 2019-01-11: "This billion-dollar decision by Novo Nordisk more than doubles the size of its North Carolina workforce and underscores the Research Triangle's global leadership in bio-manufacturing."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.